| http://www.w3.org/ns/prov#value | - ???San Diego???s Lumena Pharmaceuticals said it has initiated a global clinical program to evaluate its drug candidate LUM001 in children with Alagille syndrome, a genetic disorder that can affect the liver, heart, and other parts of the body.
|
